BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 29796623)

  • 1. The Screening Illustrator: separating the effects of lead-time and overdiagnosis in mammography screening.
    Lousdal ML; Møller MH; Kristiansen IS; Kalager M; Wisløff T; Støvring H
    Eur J Public Health; 2018 Dec; 28(6):1138-1142. PubMed ID: 29796623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Breast cancer incidence trends in Norway and estimates of overdiagnosis.
    van Luijt PA; Heijnsdijk EA; van Ravesteyn NT; Hofvind S; de Koning HJ
    J Med Screen; 2017 Jun; 24(2):83-91. PubMed ID: 27754936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mammography screening: A major issue in medicine.
    Autier P; Boniol M
    Eur J Cancer; 2018 Feb; 90():34-62. PubMed ID: 29272783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estimation of overdiagnosis using short-term trends and lead time estimates uncontaminated by overdiagnosed cases: Results from the Norwegian Breast Screening Programme.
    Michalopoulos D; Duffy SW
    J Med Screen; 2016 Dec; 23(4):192-202. PubMed ID: 26940963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overdiagnosis of invasive breast cancer due to mammography screening: results from the Norwegian screening program.
    Kalager M; Adami HO; Bretthauer M; Tamimi RM
    Ann Intern Med; 2012 Apr; 156(7):491-9. PubMed ID: 22473436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trends in aggregate cancer incidence rates in relation to screening and possible overdiagnosis: a word of caution.
    Duffy SW; Michalopoulos D; Sebuødegård S; Hofvind S
    J Med Screen; 2014 Mar; 21(1):24-9. PubMed ID: 24446330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness of and overdiagnosis from mammography screening in the Netherlands: population based study.
    Autier P; Boniol M; Koechlin A; Pizot C; Boniol M
    BMJ; 2017 Dec; 359():j5224. PubMed ID: 29208760
    [No Abstract]   [Full Text] [Related]  

  • 8. Overdiagnosis and overtreatment associated with breast cancer mammography screening: A simulation study with calibration to population-based data.
    Seigneurin A; Labarère J; François O; Exbrayat C; Dupouy M; Filippi M; Colonna M
    Breast; 2016 Aug; 28():60-6. PubMed ID: 27240167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Will supplemental screening ultrasound increase breast cancer overdiagnosis?
    Molleran VM
    Acad Radiol; 2015 Aug; 22(8):967-72. PubMed ID: 26100187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trends in lung cancer risk and screening eligibility affect overdiagnosis estimates.
    Blom EF; Ten Haaf K; de Koning HJ
    Lung Cancer; 2020 Jan; 139():200-206. PubMed ID: 31816564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estimation of overdiagnosis in breast cancer screening using a non-homogeneous multi-state model: A simulation study.
    Wu WY; Nyström L; Jonsson H
    J Med Screen; 2018 Dec; 25(4):183-190. PubMed ID: 29153013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extrapolation of pre-screening trends: Impact of assumptions on overdiagnosis estimates by mammographic screening.
    Ripping TM; Verbeek AL; Ten Haaf K; van Ravesteyn NT; Broeders MJ
    Cancer Epidemiol; 2016 Jun; 42():147-53. PubMed ID: 27153471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Overdiagnosis in mammography screening].
    Zahl PH; Maehlen J
    Tidsskr Nor Laegeforen; 2004 Sep; 124(17):2238-9. PubMed ID: 15356688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Obligate Overdiagnosis Due to Mammographic Screening: A Direct Estimate for U.S. Women.
    Hendrick RE
    Radiology; 2018 May; 287(2):391-397. PubMed ID: 29267146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overdiagnosis associated with breast cancer screening: A simulation study to compare lead-time adjustment methods.
    Seigneurin A; Labarère J; Duffy SW; Colonna M
    Cancer Epidemiol; 2015 Dec; 39(6):1128-35. PubMed ID: 26341587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. No overdiagnosis in the Norwegian Breast Cancer Screening Program estimated by combining record linkage and questionnaire information in the Norwegian Women and Cancer study.
    Lund E; Nakamura A; Thalabard JC
    Eur J Cancer; 2018 Jan; 89():102-112. PubMed ID: 29245077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening mammography: update and review of publications since our report in the New England Journal of Medicine on the magnitude of the problem in the United States.
    Bleyer A
    Acad Radiol; 2015 Aug; 22(8):949-60. PubMed ID: 26100188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overdiagnosis of breast cancer at screening is clinically insignificant.
    Feig SA
    Acad Radiol; 2015 Aug; 22(8):961-6. PubMed ID: 25797300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Breast-Cancer Tumor Size, Overdiagnosis, and Mammography Screening Effectiveness.
    Welch HG; Prorok PC; O'Malley AJ; Kramer BS
    N Engl J Med; 2016 Oct; 375(15):1438-1447. PubMed ID: 27732805
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.